Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Cash from Financing Activities (2016 - 2024)

MedWellAI (MWAI) has disclosed Cash from Financing Activities for 10 consecutive years, with -$50000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Cash from Financing Activities changed N/A to -$50000.0 in Q2 2024 year-over-year; TTM through Mar 2025 was -$50000.0, a 74.11% increase, with the full-year FY2024 number at -$243150.0, down 386.3% from a year prior.
  • Cash from Financing Activities was -$50000.0 for Q2 2024 at MedWellAI, up from -$94620.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $8.1 million in Q2 2021 to a low of -$94620.0 in Q1 2024.
  • A 5-year average of $941021.0 and a median of $2962.0 in 2020 define the central range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 106985.39% in 2021; the steepest drop was 103.63% in 2021.
  • MedWellAI's Cash from Financing Activities stood at $226816.0 in 2020, then tumbled by 100.73% to -$1659.0 in 2021, then soared by 37360.4% to $618150.0 in 2022, then tumbled by 108.33% to -$51500.0 in 2023, then grew by 2.91% to -$50000.0 in 2024.
  • Per Business Quant, the three most recent readings for MWAI's Cash from Financing Activities are -$50000.0 (Q2 2024), -$94620.0 (Q1 2024), and -$51500.0 (Q4 2023).